Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Description discloses many behavioral traits beyond annotations: multi-source cascade (EDGAR, GLEIF, OpenFIGI), graceful degradation if GLEIF/OpenFIGI unavailable, asserting nothing when multiple matches and returning figi_candidates, and explicit unresolved identifiers. This adds substantial context beyond the readOnlyHint and idempotentHint.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense but every sentence adds value. It front-loads the core purpose and usage, then details supported types and edge cases. Could be slightly reorganized with bullet points, but the information density justifies the length.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema, the description thoroughly covers input formats, supported entity types, resolution behavior, edge cases, fallbacks, and result semantics. An agent has everything needed to invoke it correctly for both company and drug lookups.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although schema coverage is 100%, the description significantly enriches parameter meaning, especially for 'value' by explaining what to pass for bonds (issuer exactly as printed), what never to include (security-class words), and providing concrete examples for ticker/CIK/name and drug names. This is essential usage nuance not in the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description explicitly states the tool resolves user-spoken names to canonical/official identifiers, using specific verbs ('resolve', 'look up', 'find') and lists supported entity types. It clearly differentiates from siblings like entity_profile and compare_entities by focusing on ID lookup rather than profiling or comparison.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit guidance: 'Use FIRST whenever you have a name but need an ID.' It also gives detailed when-to-use examples and anti-guidance for bonds (pass issuer name only, not full noun phrase), making the selection criteria unambiguous.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Several tools occupy nearly the same niche: ask_pipeworx_beta is explicitly an identical duplicate of ask_pipeworx when no experiment is active, and ask_pipeworx, ask_pipeworx_grounded, deep_research, and validate_claim all overlap as question-answering entry points. Other families like entity_profile vs compare_entities vs recent_changes and ai_visibility_check vs scan_competitor_ai_presence also blur together despite long disambiguating descriptions.

Naming Consistency4/5

All tool names use a clean, readable snake_case style, and there are strong prefix families like ask_pipeworx, polymarket_, list_, and scan_. However, the set is not uniformly verb_noun: entity_profile, deep_research, recent_alerts, pipeworx_trending, and several others are noun phrases rather than actions, so the pattern is mostly consistent but not strict.

Tool Count2/5

34 tools is well beyond the 25+ threshold where a server starts feeling bloated, and the server name 'Space Feeds' suggests a narrow niche while most of the surface is a general data research, prediction-market, memory, and subscription platform. Each tool may be useful, but as a set the scope is sprawling rather than focused.

Completeness4/5

The major workflows have good lifecycle coverage: data lookup and grounded verification, entity resolution and profiling, prediction-market analysis, memory (remember/recall/forget), subscriptions (subscribe/list/unsubscribe/recent_alerts), and feed reading (list/read/fetch) are all represented. Minor gaps include a direct pipeworx:// citation reader and feed curation or management operations, but agents can work around those.